Annual Revenue
$2.81 M
-$3.54 M-55.77%
December 31, 2023
Summary
- As of February 12, 2025, FULC annual revenue is $2.81 million, with the most recent change of -$3.54 million (-55.77%) on December 31, 2023.
- During the last 3 years, FULC annual revenue has fallen by -$6.02 million (-68.21%).
- FULC annual revenue is now -85.36% below its all-time high of $19.16 million, reached on December 31, 2021.
Performance
FULC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- FULC quarterly revenue is not available.
Performance
FULC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- FULC TTM revenue is not available.
Performance
FULC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
FULC Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.8% | - | - |
| 3 y3 years | -68.2% | - | - |
| 5 y5 years | - | - | - |
FULC Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.4% | at low | ||||
| 5 y | 5-year | -85.4% | at low | ||||
| alltime | all time | -85.4% | at low |
Fulcrum Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $80.00 M(+9084.8%) | $81.63 M(+2810.2%) |
| Dec 2023 | $2.81 M(-55.8%) | $871.00 K(+14.8%) | $2.81 M(+7.1%) |
| Sep 2023 | - | $759.00 K(-13.8%) | $2.62 M(-13.9%) |
| Jun 2023 | - | $880.00 K(+198.3%) | $3.04 M(-24.8%) |
| Mar 2023 | - | $295.00 K(-56.9%) | $4.04 M(-36.2%) |
| Dec 2022 | $6.34 M | $685.00 K(-42.1%) | $6.34 M(-40.8%) |
| Sep 2022 | - | $1.18 M(-37.1%) | $10.71 M(-25.9%) |
| Jun 2022 | - | $1.88 M(-27.4%) | $14.47 M(-14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $2.59 M(-48.8%) | $16.97 M(-11.5%) |
| Dec 2021 | $19.16 M(+117.2%) | $5.06 M(+2.5%) | $19.16 M(+4.5%) |
| Sep 2021 | - | $4.93 M(+12.6%) | $18.33 M(+20.3%) |
| Jun 2021 | - | $4.38 M(-8.5%) | $15.24 M(+18.5%) |
| Mar 2021 | - | $4.79 M(+13.3%) | $12.86 M(+45.8%) |
| Dec 2020 | $8.82 M | $4.22 M(+128.6%) | $8.82 M(+91.9%) |
| Sep 2020 | - | $1.85 M(-7.6%) | $4.60 M(+67.2%) |
| Jun 2020 | - | $2.00 M(+166.7%) | $2.75 M(+266.7%) |
| Mar 2020 | - | $750.00 K | $750.00 K |
FAQ
- What is Fulcrum Therapeutics annual revenue?
- What is the all time high annual revenue for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Fulcrum Therapeutics?
- What is the all time high TTM revenue for Fulcrum Therapeutics?
What is Fulcrum Therapeutics annual revenue?
The current annual revenue of FULC is $2.81 M
What is the all time high annual revenue for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual revenue is $19.16 M
What is Fulcrum Therapeutics annual revenue year-on-year change?
Over the past year, FULC annual revenue has changed by -$3.54 M (-55.77%)
What is the all time high quarterly revenue for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly revenue is $80.00 M
What is the all time high TTM revenue for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM revenue is $81.63 M